March 1, 2017
How These Healthcare Stocks are Faring?: Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma
According to Deloitte’s 2017 Global Health Care Sector Outlook the challenges of providing and funding healthcare around the world are likely to continue this year due to the rising demands and associated spending of the aging population, the growing prevalence of chronic diseases and comorbidities, the development of costly clinical innovations, increasing patient expectations, and continued economic turbulence.
